News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: volgoat post# 255381

Sunday, 02/28/2016 8:18:13 AM

Sunday, February 28, 2016 8:18:13 AM

Post# of 347009
What is better than Fast Track Approval? Double or Triple Fast Track Approval : ) YES, by ending Sunrise now you cut 10 months off of the total time for full data access and legal access to show someone that is quite interested in moving full speed ahead with PS Targeting combinations... funny how long many keep saying there are problems, when the only problem here is that many can't keep stop worrying about what Peregrine will do next.

Ok, so Pphm is going to apply for BTD,but cancels all other chemo trials, makes perfect sense if you are a hold and hope investor stuck with nothing.

Good luck with your dreams and wishes, but Peregrine is done and investors will see a RS sooner than any data comes in if it ever comes in fro I/O..



Why would Peregrine apply for BTD for Bavi+Doce Volgoat? Who says that Doce is the best chemo (it works... but doubt its the best) and all are moving towards IO combinations so we have many areas now where BTD will be applied for.

You also forgetting that the BLA application is still moving forward, since the Bavi+Doce arm "IS AS EXPECTED" and with all the combo data (including the hundreds more human data of Sunrise) will all be filling out that BLA that Garnick talked about that was 100,000 pages long already


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y